Northern Trust
GPCR icon

Northern Trust’s Structure Therapeutics GPCR Stock Holding History

Northern Trust’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273K Buy
+5,080
New +$225K ﹤0.01% 3837
2026
Q1 		– Sell
-3,645
Closed -$254K – 4462
2025
Q4 		$254K Buy
+3,645
New +$149K ﹤0.01% 3897

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Northern Trust's GPCR Position: Q2 2026 in Review

Northern Trust opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 5,080 shares worth $273K. The stake represents ﹤0.01% of the portfolio and ranks #3837 among its holdings. This is a return to the name: Northern Trust previously reported a position in GPCR as recently as Q4 2025.

Northern Trust first reported a position in GPCR in Q4 2025 and has held it in 2 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Northern Trust held 5,080 shares of Structure Therapeutics worth $273K as of Q2 2026.
  • Structure Therapeutics was a new Northern Trust position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3837 holding.
  • Northern Trust first reported a position in Structure Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.